Felix Gonzalez Lopez De Turiso

Person

San Mateo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
ASK1 inhibiting agents
- Patent number 11,999,715
- Issue date Jun 4, 2024
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridine macrocycle compounds as ASK1 inhibiting agents
- Patent number 11,897,898
- Issue date Feb 13, 2024
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ASK1 inhibiting agents
- Patent number 11,814,362
- Issue date Nov 14, 2023
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bisamide sarcomere activating compounds and uses thereof
- Patent number 11,780,826
- Issue date Oct 10, 2023
- Amgen Inc.
- Luke Ashcraft
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CIS-morpholinone and other compounds as MDM2 inhibitors for the tre...
- Patent number 11,407,721
- Issue date Aug 9, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 11,306,107
- Issue date Apr 19, 2022
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bisamide sarcomere activating compounds and uses thereof
- Patent number 11,299,479
- Issue date Apr 12, 2022
- Cytokinetics, Inc.
- Luke Ashcraft
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ASK1 inhibiting agents
- Patent number 11,168,095
- Issue date Nov 9, 2021
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bisamide sarcomere activating compounds and uses thereof
- Patent number 10,899,746
- Issue date Jan 26, 2021
- Amgen Inc.
- Luke Ashcraft
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 9,873,701
- Issue date Jan 23, 2018
- Amgen Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 9,873,704
- Issue date Jan 23, 2018
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
- Patent number 9,376,425
- Issue date Jun 28, 2016
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline derivitives and their uses
- Patent number 8,940,724
- Issue date Jan 27, 2015
- Amgen Inc.
- Timothy D. Cushing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,901,135
- Issue date Dec 2, 2014
- Amgen Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,835,432
- Issue date Sep 16, 2014
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic inhibitors of hydroxysteroid dehydrogenases
- Patent number 8,765,788
- Issue date Jul 1, 2014
- Amgen Inc.
- Jay P. Powers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,765,940
- Issue date Jul 1, 2014
- Amgen Inc.
- Matthew Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,716,290
- Issue date May 6, 2014
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,633,313
- Issue date Jan 21, 2014
- Amgen Inc.
- Timothy David Cushing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,586,739
- Issue date Nov 19, 2013
- Amgen Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BTK INHIBITORS
- Publication number 20240327380
- Publication date Oct 3, 2024
- Biogen MA Inc.
- Brian T. Hopkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
- Publication number 20240158372
- Publication date May 16, 2024
- Amgen Inc.
- Luke ASHCRAFT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ASK1 INHIBITING AGENTS
- Publication number 20240109867
- Publication date Apr 4, 2024
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS
- Publication number 20240083900
- Publication date Mar 14, 2024
- Biogen MA Inc.
- Brian T. Hopkins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20230052348
- Publication date Feb 16, 2023
- Amgen Inc.
- Sean P BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
- Publication number 20220281850
- Publication date Sep 8, 2022
- Amgen Inc.
- Luke ASHCRAFT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20220169611
- Publication date Jun 2, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ASK1 INHIBITING AGENTS
- Publication number 20210317103
- Publication date Oct 14, 2021
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINE MACROCYCLE COMPOUNDS AS ASK1 INHIBITING AGENTS
- Publication number 20210300946
- Publication date Sep 30, 2021
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ASK1 INHIBITING AGENTS
- Publication number 20210115020
- Publication date Apr 22, 2021
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
- Publication number 20200223829
- Publication date Jul 16, 2020
- Amgen Inc.
- Luke Ashcraft
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
- Publication number 20200223830
- Publication date Jul 16, 2020
- Amgen Inc.
- Luke Ashcraft
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20200048265
- Publication date Feb 13, 2020
- Amgen Inc.
- Yi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ASK1 INHIBITING AGENTS
- Publication number 20190359634
- Publication date Nov 28, 2019
- Biogen MA Inc.
- Felix Gonzalez Lopez de Turiso
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20190062276
- Publication date Feb 28, 2019
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...
- Publication number 20180354918
- Publication date Dec 13, 2018
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20180105532
- Publication date Apr 19, 2018
- Amgen Inc.
- Yi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20170144971
- Publication date May 25, 2017
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20160333017
- Publication date Nov 17, 2016
- Amgen Inc.
- Minna BUI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20160137667
- Publication date May 19, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...
- Publication number 20160002185
- Publication date Jan 7, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20150045361
- Publication date Feb 12, 2015
- Amgen Inc.
- Yi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140315895
- Publication date Oct 23, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20140235629
- Publication date Aug 21, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20140206694
- Publication date Jul 24, 2014
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140011796
- Publication date Jan 9, 2014
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20130267524
- Publication date Oct 10, 2013
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20130267526
- Publication date Oct 10, 2013
- Amgen, Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY

Felix Gonzalez Lopez De Turiso

Person

Patents Grantslast 30 patents

ASK1 inhibiting agents

Pyridine macrocycle compounds as ASK1 inhibiting agents

ASK1 inhibiting agents

Bisamide sarcomere activating compounds and uses thereof

CIS-morpholinone and other compounds as MDM2 inhibitors for the tre...

Compounds that inhibit MCL-1 protein

Bisamide sarcomere activating compounds and uses thereof

ASK1 inhibiting agents

Bisamide sarcomere activating compounds and uses thereof

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Quinoline derivitives and their uses

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Tricyclic inhibitors of hydroxysteroid dehydrogenases

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Patents Applicationslast 30 patents

BTK INHIBITORS

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

ASK1 INHIBITING AGENTS

PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

ASK1 INHIBITING AGENTS

PYRIDINE MACROCYCLE COMPOUNDS AS ASK1 INHIBITING AGENTS

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

ASK1 INHIBITING AGENTS

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

HETEROCYCLIC COMPOUNDS AND THEIR USES

ASK1 INHIBITING AGENTS

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...

HETEROCYCLIC COMPOUNDS AND THEIR USES

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

HETEROCYCLIC COMPOUNDS AND THEIR USES

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...

HETEROCYCLIC COMPOUNDS AND THEIR USES

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

HETEROCYCLIC COMPOUNDS AND THEIR USES

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

HETEROCYCLIC COMPOUNDS AND THEIR USES

HETEROCYCLIC COMPOUNDS AND THEIR USES